GSK Investigational Site

Santiago de Compostela/La Coruña 15706

0 studies enrolling now · 4 studies all time

What they study most

Arthritis, Rheumatoid, Asthma, Atherosclerosis

Studies at this site

• Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA) — Stopped early
• Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma Patients — Completed
• A Phase 2a Study to Evaluate the Effects of Sirukumab in Subjects With Severe Poorly Controlled Asthma — Withdrawn before enrolling
• SB-480848 In Subjects With Coronary Heart Disease — Completed